Sexual contact is the primary way adults acquire Ureaplasma, but it is not the only route, and the organism is so common that calling it a straightforward “sexually transmitted infection” oversimplifies things. Ureaplasma species colonize the genital tracts of roughly 40 to 80 percent of sexually mature women and a substantial fraction of men, often without causing any symptoms at all. That prevalence alone hints that the story of how you “got” Ureaplasma is more nuanced than a single encounter or a single partner.
Why Ureaplasma Is So Common in the First Place
Ureaplasma belongs to a group of very small bacteria called Mollicutes that lack a cell wall, which makes them unusual among bacteria and also makes them invisible to certain antibiotics. There are two species that colonize humans: Ureaplasma urealyticum and Ureaplasma parvum. Of the two, U. parvum is found more frequently in the general population, while U. urealyticum is more closely linked to symptomatic disease, particularly urethritis in men.1PubMed Central. Efficacy of standard therapies against Ureaplasma species and persistence among men with non-gonococcal urethritis enrolled in a randomised controlled trial
The sheer colonization rates tell the story of how easily Ureaplasma spreads. In sexually active women, ureaplasmas have been detected in 40 to 80 percent of vaginal or cervical samples.2PubMed Central. Mollicutes in vaginal microbiology: Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum and Mycoplasma genitalium One study at a sexual health clinic found Ureaplasma urealyticum in roughly half of all women tested, regardless of their diagnosis or whether they had any symptoms.3BMJ Journals (British Journal of Venereal Diseases). Genitourinary infection with Ureaplasma urealyticum in women attending a sexually transmitted diseases clinic In men, the rates are lower but still substantial: a survey of healthy, asymptomatic young men detected U. urealyticum in 12 percent and U. parvum in 23 percent.4PubMed. Detection of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum DNAs in urine from asymptomatic healthy young Japanese men These are people with no complaints whatsoever, walking around with Ureaplasma as part of their normal microbial landscape.
Sexual Transmission as the Main Route
For adults, genital-to-genital or oral-to-genital contact during sex is the dominant way Ureaplasma gets passed from one person to another. The organism lives on mucous membranes of the urethra, vagina, and cervix, and it transfers readily during unprotected intercourse. Epidemiological studies consistently show that colonization rates rise sharply with the onset of sexual activity and increase with the number of lifetime sexual partners. People who have never been sexually active have much lower carriage rates.
This does not mean, however, that a positive Ureaplasma result points to a specific partner or a recent encounter. Because the organism can persist in the genital tract for months or years without causing noticeable problems, you could have acquired it from any previous sexual contact, not necessarily a recent one. And because it can exist silently in both partners, it is often impossible to determine who transmitted it to whom. Couples sometimes discover that both partners carry Ureaplasma without either ever having had symptoms, which can spark anxiety and relationship tension that the clinical picture does not warrant.
Condom use reduces transmission of many sexually transmitted organisms, and Ureaplasma is no exception, though the evidence is less systematically studied than for chlamydia or gonorrhea. Because Ureaplasma is not routinely screened for in standard STI panels, most carriers never know they have it, and they transmit it unknowingly.
Vertical Transmission From Mother to Baby
The second well-established route is from a colonized mother to her newborn during delivery. As the baby passes through the birth canal, it comes into contact with the mother’s vaginal and cervical microbes, and Ureaplasma is among them. One study that tracked transmission directly found that about 68 percent of newborns born to carrier mothers also tested positive.5PubMed Central. Mycoplasma and Ureaplasma carriage in pregnant women: the prevalence of transmission from mother to newborn Rates varied by species: every newborn born to a U. parvum-positive mother acquired the organism, while roughly 29 percent of newborns born to U. urealyticum-positive mothers did.5PubMed Central. Mycoplasma and Ureaplasma carriage in pregnant women: the prevalence of transmission from mother to newborn
Transmission can also happen before delivery. When Ureaplasma ascends into the uterus, it can infect the amniotic fluid and fetal membranes, a condition called chorioamnionitis. Case reports have documented vertical transmission through this route, where the baby acquires the infection in utero rather than during passage through the birth canal.6PubMed. Chorioamnionitis as an apparent source of vertical transmission of Staphylococcus cohnii and Ureaplasma urealyticum to a neonate This matters clinically because prenatal exposure, particularly in premature infants, has been linked to respiratory complications including bronchopulmonary dysplasia, a chronic lung condition that affects preterm babies.7PubMed Central. Role of Ureaplasma Respiratory Tract Colonization in Bronchopulmonary Dysplasia Pathogenesis: Current Concepts and Update
Colonization acquired at birth is usually transient in healthy, full-term infants. Their developing immune systems typically clear the organism within months. In preterm or very low-birth-weight babies, the picture can be different, and persistent colonization is more concerning.
Can You Get Ureaplasma Without Sexual Contact?
This is one of the most anxiety-provoking questions for people who test positive, especially if they are in a monogamous relationship or have not recently been sexually active. The honest answer is that non-sexual horizontal transmission between adults has not been well-studied and is not considered a major route, but it cannot be categorically ruled out either. Ureaplasma does not survive long outside the body, which limits casual transmission via shared towels, toilet seats, or similar surfaces. There is no credible evidence that you can pick up Ureaplasma from a swimming pool, gym equipment, or casual skin contact.
However, a few scenarios make nonsexual acquisition plausible. Newborns colonized through vertical transmission may carry the organism into childhood, and in some cases it could persist. Rarely, medical procedures involving the urogenital tract could theoretically introduce the organism, though this is not documented as a significant source. The practical takeaway is that sexual contact remains the overwhelmingly likely explanation for a new positive result in a sexually active adult, but the possibility of long-standing colonization from a distant past encounter or even from birth means that a positive test does not automatically equal recent infidelity.
Colonization Versus Infection
This distinction is critical and often gets lost in the panic of a positive test result. Being colonized means the organism is present on your mucosal surfaces. Being infected means it is causing tissue damage and symptoms. Most people who carry Ureaplasma are colonized, not infected. Studies of asymptomatic women in various populations consistently find colonization rates in the range of 14 to 16 percent even when screening specifically for the more pathogenic U. urealyticum species.8PubMed Central. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum in asymptomatic women in Northern Greece9PubMed Central. Prevalence of Ureaplasma urealyticum, Mycoplasma hominis and Chlamydia trachomatis in symptomatic and asymptomatic patients When both species are included, the numbers are far higher.
This is why many clinicians are cautious about testing for Ureaplasma routinely. A positive result in someone without symptoms creates a dilemma: treat an organism that might be harmlessly coexisting, or leave it alone and risk having missed something? The medical community generally leans toward not testing asymptomatic people for Ureaplasma, because the high background rate of colonization means most positive results do not indicate disease.
When Ureaplasma Does Cause Problems
Despite being a common commensal, Ureaplasma can genuinely cause disease in certain circumstances. In men, U. urealyticum (specifically biovar 2) has been linked to nongonococcal urethritis, the kind of urethral inflammation that produces burning with urination and discharge but tests negative for gonorrhea and chlamydia.10PubMed Central. The Role of Ureaplasma spp. in the Development of Nongonococcal Urethritis and Infertility among Men There is also ongoing research into whether Ureaplasma affects sperm quality and male fertility, though definitive conclusions have been elusive.
In women, the evidence for Ureaplasma as a standalone cause of cervicitis or pelvic inflammatory disease is surprisingly thin. A systematic review found that only two studies met quality criteria for evaluating cervicitis, and they reached conflicting conclusions. The review concluded that U. urealyticum appears to play a limited role as a pathogen in female cervicitis, pelvic inflammatory disease, and genital discomfort.11PubMed. Ureaplasma urealyticum: the Role as a Pathogen in Women’s Health, a Systematic Review That said, Ureaplasma was detected in 40 percent of women with recurrent or persistent cervicitis in one clinical study, suggesting it may play a role in cases that fail to respond to standard treatment.12PubMed Central. Clinical and Microbiological Profile of Recurrent and/or Persistent Cervicitis in Patients Attending Suraksha Clinic
Where the evidence is more convincing is in pregnancy. Ureaplasma infections have been associated with premature rupture of membranes, placental inflammation, and newborn respiratory distress syndrome.13PubMed Central. The impact of Ureaplasma infections on pregnancy complications Specific serovars seem to matter: vaginal colonization with U. parvum serovar 3 was linked to a significantly increased risk of very early preterm birth (before 32 weeks), while other serovars were not.14American Journal of Obstetrics and Gynecology. Vaginal Ureaplasma parvum serovars and spontaneous preterm birth The risk climbed further in women who also had bacterial vaginosis or a history of preterm delivery. This kind of serovar-level specificity is a big part of why blanket screening remains controversial: detecting “Ureaplasma” without knowing which species and serovar does not tell you much about actual risk.15PubMed. Mycoplasma/Ureaplasma infection in pregnancy: to screen or not to screen
The Vaginal Microbiome Factor
One of the more interesting findings in recent research is that context matters as much as the organism itself. The vaginal microbiome is a community, and whether Ureaplasma behaves as a harmless bystander or a troublemaker depends partly on what else is living alongside it. A study examining pregnant women found that when Ureaplasma and Prevotella (another bacterium associated with preterm birth) coexisted with abundant Lactobacillus, pregnancy outcomes were normal. The protective presence of Lactobacillus seemed to keep those potentially harmful organisms in check.16Scientific Reports. Ureaplasma and Prevotella colonization with Lactobacillus abundance during pregnancy facilitates term birth
Conversely, when Lactobacillus is depleted and the vaginal environment shifts toward bacterial vaginosis, Ureaplasma colonization appears to become more problematic. Women with persistent vaginal complaints after bacterial vaginosis treatment showed significantly higher relative abundance of Ureaplasma compared to those who recovered fully.17PubMed Central. The vaginal microbiota in the course of bacterial vaginosis treatment This suggests that “getting” Ureaplasma is only part of the equation; what the rest of your microbiome looks like helps determine whether it causes any trouble.
How Ureaplasma Is Detected
If you have been told you have Ureaplasma, it was almost certainly detected through one of two methods: culture or PCR (a molecular test that looks for the organism’s DNA). Both are reliable, but PCR has some practical advantages. It returns results in about a day rather than the two to five days required for culture, and its sensitivity is slightly higher, catching some infections that culture misses.18PubMed. Polymerase chain reaction versus culture for detection of Ureaplasma urealyticum and Mycoplasma hominis in the urogenital tract of adults and the respiratory tract of newborns PCR also has the advantage of distinguishing between U. urealyticum and U. parvum, which culture alone often cannot do easily.19PubMed Central. Rapid PCR Detection of Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum
That species distinction is clinically relevant. If you test positive for U. parvum only and have no symptoms, most experts would consider that a normal finding not requiring treatment. A positive U. urealyticum result with symptoms, especially in the setting of urethritis in men or recurrent pregnancy complications, gets taken more seriously. This is worth asking about if you receive a positive result: which species was detected, and does the clinical picture warrant treatment?
Treatment and the Growing Concern About Resistance
When treatment is warranted, the first-line options are typically antibiotics from the tetracycline class (doxycycline) or macrolide class (azithromycin). Because Ureaplasma lacks a cell wall, common antibiotics that target cell wall synthesis, such as penicillins and cephalosporins, are useless against it. This is a frequent source of frustration for patients who have already been prescribed one of those drugs for a suspected urinary tract infection and seen no improvement.
Antibiotic resistance is a real and growing issue. Resistance to macrolides arises from mutations in the 23S ribosomal RNA gene, and several specific mutations have been documented in clinical isolates.20PubMed. Transition mutations in 23S rRNA account for acquired resistance to macrolides in Ureaplasma urealyticum Tetracycline resistance is typically driven by a mobile genetic element that can jump between bacteria, meaning resistance can spread through bacterial populations relatively quickly.21Journal of Antimicrobial Chemotherapy. Antibiotic resistance among Ureaplasma spp. isolates: cause for concern? Fluoroquinolone resistance, while less common, also occurs through accumulation of mutations.22PubMed Central. Antimicrobial Resistance in Clinical Ureaplasma spp. and Mycoplasma hominis and Structural Mechanisms Underlying Quinolone Resistance
For patients dealing with persistent or recurrent infections, susceptibility testing can guide antibiotic choice, though not all labs offer it for Ureaplasma. If a first course of doxycycline or azithromycin fails, the next step typically involves a different drug class, and your provider may send a sample specifically for resistance testing.
Ureaplasma in People With Weakened Immune Systems
In people with healthy immune systems, Ureaplasma rarely strays beyond the genital and urinary tracts. But in immunocompromised patients, particularly those with problems producing antibodies, the organism can invade joints, wounds, and even the central nervous system. A review of invasive Ureaplasma infections found that about 71 percent occurred in patients with antibody deficiencies, including those receiving rituximab (a drug that depletes a type of immune cell involved in antibody production). Septic arthritis was the most common presentation, accounting for 88 percent of these invasive cases.23Open Forum Infectious Diseases. Invasive Ureaplasma Infection in Patients Receiving Rituximab and Other Humoral Immunodeficiencies—A Case Report and Review of the Literature
Among the remaining cases were patients with prosthetic implant infections affecting hips, knees, and heart valves. Reassuringly, the majority of these patients (about 79 percent) improved with targeted antibiotic therapy.23Open Forum Infectious Diseases. Invasive Ureaplasma Infection in Patients Receiving Rituximab and Other Humoral Immunodeficiencies—A Case Report and Review of the Literature If you are on immunosuppressive therapy and develop unexplained joint inflammation or fever, Ureaplasma is not the first thing most doctors think of, but it is worth raising as a possibility, especially if standard cultures keep coming back negative (again, because this organism does not grow on standard lab plates).
The Partner Conversation
A Ureaplasma diagnosis inevitably raises questions about partners, especially in committed relationships. It is worth understanding a few things before that conversation happens. First, because colonization can persist silently for years, a positive test today does not mean a recent acquisition. Second, because carriage rates are so high in the general population, both partners in a sexually active couple may well be positive. Third, there is no universal guideline recommending partner treatment when Ureaplasma is found incidentally. Some practitioners will treat both partners when one has symptomatic urethritis or recurrent cervicitis, reasoning that the organism could simply be passed back and forth. Others treat only the symptomatic individual.
The lack of consensus on partner management reflects the underlying ambiguity of Ureaplasma’s clinical significance. It is not managed like chlamydia or gonorrhea, where positive tests trigger mandatory partner notification in many jurisdictions. Ureaplasma falls into a gray zone: too common to be treated like a classic STI, but too capable of causing specific complications to be entirely ignored. The best approach is an honest conversation with your healthcare provider about whether your specific situation, including your symptoms, your reproductive plans, and the species detected, warrants treatment for one or both partners.
Why Standard STI Panels Miss Ureaplasma
Many people are surprised to learn that Ureaplasma is not included in routine STI screening. Standard panels typically test for chlamydia, gonorrhea, syphilis, HIV, and sometimes hepatitis and trichomoniasis. Ureaplasma is left out partly because of its high colonization rate in healthy people (testing would produce an enormous number of positive results that do not indicate disease) and partly because the clinical significance of asymptomatic carriage remains debated. Testing is generally reserved for cases where someone has symptoms that standard workups have failed to explain: persistent urethritis after chlamydia and gonorrhea have been ruled out, recurrent pregnancy loss, or chronic pelvic symptoms.
Some direct-to-consumer testing companies now offer Ureaplasma panels, which has led to more people discovering asymptomatic colonization and, understandably, worrying about it. If you tested positive through one of these panels and have no symptoms, talking to a clinician before pursuing treatment is a reasonable step. Treating asymptomatic colonization with antibiotics carries its own risks, including disrupting your normal microbiome and contributing to antibiotic resistance, without clear evidence of benefit.